2026 Scientific Sessions

State of the SHD (Structural Heart Disease) Union

This session is structured as a comprehensive "State of the Union" overview, emphasizing a year-in-review (focusing on key 2025-2026 advancements from trials, devices, and outcomes) while providing a forward-looking glimpse into emerging trends and future innovations. These talks will highlight real-world data, procedural refinements, and interdisciplinary implications for structural heart disease.
Introductory Remarks
State of the Union: Transcatheter Aortic Valve Interventions
David A. Wood, M.D., UBC Centre for Cardiovascular Innovation, Vancouver, BC, CANADA
Discussion
State of the Union: Transcatheter Mitral Valve Interventions
Matthew Cavender, M.D., The University of North Carolina at Chapel Hill, Chapel Hill, NC
Discussion
State of the Union: Transcatheter Tricuspid Valve Interventions
David J. Cohen, M.D., FSCAI, St. Francis Hospital, New York, NY
Discussion
State of the Union: LAAO and other Plug Based Interventions
Jacqueline Saw, M.D., FSCAI, Vancouver General Hospital, Vancouver, BC, Canada
Discussion